What is the state-of-the-art MR-LINAC and how is it a revolutionary device for radiotherapy treatment? Here, we interview Prof Uwe Oelfke, Head of the Joint Department of Physics at The Institute of Cancer Research (ICR) and The Royal Marsden. He shares his involvement with the MR-LINAC project and his hopes for the future of this technology. Read here for more…
Here we interview Gregg Sando, founder of Cell Medica and Dr. Martin Pule , founder of Autolus. Both recently spoke at the SIULondon event ‘Advances in Immunotherapy’. Read here to find out more about their career journeys into commercialization of immunotherapies and what they see for the future of this field.
Ahead of the SIULondon ‘Advances in Immunotherapy’ event, we interviewed Dr. Bo Kara from GlaxoSmithKline (GSK) and Dr. Jacqueline Barry from Cell and Gene Therapy (CGT) Catapult. Both experts share their role in supporting the cell and gene therapy field and give their insights on industry science and more… Read on here.
Here’s more insight into the worlds of investing and innovating. SIULondon interviewed Tomi Fyrqvist of AXA Venture Partners and Luca Schnettler of HealthyHealth. Read their motivations for being involved in venture capitalism and entrepreneurship.
Ahead of SIULondon's upcoming event 'Young Innovators vs Investors' on 20th March, we interviewed another anticipated member of the discussion panel - Devika Wood, Founder and CEO of Vida, a healthcare technology platform company focusing on delivering personalized and quality care. She has also featured on the Forbes '30 under 30' list 2018. Read here for her startup story and advice for budding entreprenuers.
Ahead of SIULondon's event on 20th March, 2018 (Young Innovators vs Investors), we had the opportunity to interview two of the speakers- Paul Dowling, CEO of Dreamstake & Maciej Manka, Student at UCL . They represent the investors and innovators community respectively, sharing their story and advice on entering and succeeding in the innovation and startup scene.
Dr. José Airas, a Director of Inhouse Consulting at Merck KGaA, is scheduled to speak at SIU's “Academic Breakout: Alternative Careers in Biotech” on January 25th, 2018 in Frankfurt am Main. Here, he gives us a preview of advice on transitioning from academia to industry ahead of his talk.
Dr. Bert Sakmann, MD, PhD was a guest speaker at our SIU Katowice event the 'Brain in a nutshell'. Here, we have an exclusive interview with the Nobel Laureate in Medicine and Physiology (1991). He discusses the challenges leading up to his award winning work on cellular ion channels , explains his current research on digital neuroanatomy at the Max Planck Institute and offers his opinion on Artificial Intelligence.
Mr Paweł Soluch is the CEO of the Neuro Device Group, a company that has built a strong portfolio of biomedical products to address demand in the scientific market for new equipment and to attempt to solve ideologies where research has otherwise failed. Here he gives us insight into the medtech field and shares his experience as both a scientist and entrepreneur.
Prof. Dobson is currently the Principal Fellow at Warwick Manufacturing Group, University of Warwick, has visiting professorships at UCL and King’s College, London and was previously the Academic Director of the Begbroke Science Park at the University of Oxford. In this interview, he has shared his expert opinion on the biotechnology research and policy landscape, and redefines the hard lessons for innovators.
It is a common struggle for many aspiring scientists to gain knowledge and support to commercialise their scientific ideas. We interviewed Dr Jeff Skinner, the Executive Director of the Institute of Innovation and Entrepreneurship at London Business School (LBS).
Integrating digital innovation into medicine is a very up-and-coming trend. Can we say the same when it comes to mental health? Here to tell us is Dr Samantha Scholtz, a consultant psychiatrist and R&D manager for the West London Mental Health Trust.
Monsters growling, robots talking and creatures screeching. Remind you of that movie you watched not long ago or the latest computer game you started playing? Ever wondered how these sounds come to be? Then read our interview with Orfeas Boteas, an entrepreneur who started a company to design sounds, after he did his master's on producing a sound tool.
When he decided to enter the SIU-Naturejobs writing competition, our regular contributor Devon Sheppard wanted to write about an entrepreneur who came from an academic background. He interviewed Dr Vanessa Gray-Schopfer, one of the founders of Omniscience, to get first-hand information about starting a company. Here is that interview.
Thinking outside the box is a daily practice for all scientists whatever path they take. Starting their own company is no exception and in this article we bring you the interview we conducted with Dr Zografos who stepped outside of the box even further than in a typical scenario: Bringing a research idea out of an academic lab combined with crowdfunding to get a company started. Read on for an inspiring story.
SIU is all about building bridges between academia and industry. National research facilities are the perfect platforms where these bridges can be built. They provide state-of-the-art technologies and are open to both industry and academia. In this article we tell you how they work and how they can lead to new ideas and new companies.
We are kicking off the new year with the interview we conducted with Genomics PLC, an Oxford spinout with exciting aims. The company works on uncovering the relationship between human genomic data and disease diagnosis. In this article we bring to you the story of how the company was founded and get advice from the founders for new entrepreneurs.
How CAN you start your own business? In this article, SIU is in conversation with Avinash Nanda of Saïd Business School, University of Oxford, who is also a co-founder of the Refugee Connect project, about the 'what', the 'when' and the 'how' of getting started.
A unique insight into the world of a start-up: SIU recently interviewed Alizé Pennec, a scientist from Oxford Biotrans about the her story of transitioning from academia to industry and the journey of this young company.